Skip to content

BREAKING NEWS: FDA Approves First Treatment for Friedreich’s Ataxia. LEARN MORE!

National Ataxia Foundation

2023 AAC

Larissa Nitschke

Staff Editor & Staff Writer

Houston, Texas, USA

Larissa Nitschke is a PhD candidate in the Integrative Molecular and Biomedical Sciences Program at Baylor College of Medicine (BCM) in Houston, Texas. She earned her Bachelor’s degree in Biology from the Heinrich-Heine-University Düsseldorf, Germany. In 2015, she joined the laboratory of Dr. Huda Zoghbi at BCM. Her research focuses on the understanding the post-transcriptional and post-translational regulation of ATXN1, the causative gene for Spinocerebellar Ataxia Type 1 (SCA1).

Print Friendly, PDF & Email
Translate »
National Ataxia Foundation

Join NAF

Become a member for FREE!
It only takes a few moments.

Sign up today to receive:

  • News and research opportunities about your specific type of Ataxia as they become available
  • Early access to free webinars
  • eNewsletter and Generations publications